Liquidia Technologies (LQDA)
(Delayed Data from NSDQ)
$20.31 USD
+0.24 (1.20%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $20.35 +0.04 (0.20%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
LQDA 20.31 +0.24(1.20%)
Will LQDA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LQDA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LQDA
Vericel Corporation (VCEL) Reports Q2 Loss, Lags Revenue Estimates
Insmed Stock Jumps 29% on Encouraging PAH Study Results
LQDA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Misses Revenue Estimates
Merus N.V. (MRUS) Reports Q1 Loss, Tops Revenue Estimates
Liquidia Technologies (LQDA) Surges 13.2%: Is This an Indication of Further Gains?
Other News for LQDA
Liquidia Corp (LQDA) Announces Upcoming Second Quarter 2025 Financial Results | LQDA stock news
Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025 | LQDA ...
Liquidia (LQDA) Shares Drop Amid Legal Battle with United Therapeutics
United Therapeutics up 7%, Liquidia down 9% in afternoon trading
Bleecker Street Research short United Therapeutics, long Liquidia